During the past decade, Hautzentrum Friedrichshain Studien conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hautzentrum Friedrichshain Studien" are "Dermatitis, Atopic" (2 trials), "Dermatitis" (1 trials), "Eczema" (1 trials), "Genetic Diseases, Inborn" (1 trials) and "Hypersensitivity" (1 trials). Many other conditions were trialed in "Hautzentrum Friedrichshain Studien" in a lesser frequency.

Most popular intervention types in "Hautzentrum Friedrichshain Studien" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "PF-04965842 100 mg" (1 trials) and "PF-04965842 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hautzentrum Friedrichshain Studien" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hautzentrum Friedrichshain Studien". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hautzentrum Friedrichshain Studien, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hautzentrum Friedrichshain Studien, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".